XML 29 R17.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock Options and Awards
12 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Options and Awards
Stock Based Incentive Compensation
 
In 1997, the Company adopted the 1997 Stock Option Plan (the “1997 Plan”), and authorized 199,650 shares of common stock to be reserved for issuance pursuant to the 1997 Plan. The 1997 plan expired in 2007. Because the 1997 Plan has expired, no further awards will be issued under this plan. In 2003, the Company adopted the 2003 Stock Incentive Plan (the “2003 Plan”) and authorized 200,000 shares of common stock to be reserved for issuance pursuant to the 2003 Plan. The 2003 plan expired in 2013. Because the 2003 Plan has expired, no further awards will be issued under this plan. In 2007, the Company adopted the 2007 Stock Incentive Plan (the “2007 Plan”) and authorized 250,000 shares of common stock to be reserved for issuance pursuant to the 2007 Plan. As of September 30, 2016, there were 36,217 shares available to be granted under the 2007 Plan. In 2015, the Company adopted the 2015 Stock Incentive Plan (the “2015 Plan”) and authorized 300,000 shares of common stock to be reserved for issuance pursuant to the 2015 Plan. As of September 30, 2016, there were 233,248 shares available to be granted under the 2015 Plan. Under all of the stock incentive plans, both incentive stock options and non-qualified stock options may be granted to officers, key employees and other persons providing services to the Company. The 2003 Plan and 2007 Plan also provide for awards of nonvested shares of common stock. All of the Company's stock incentive plans have a ten year life. The total number of available shares under all plans for future awards was 269,465 as of September 30, 2016.
 
Awards issued under any of the stock option plans are not affected by termination of the plan. The Company issues stock options at their fair market value on the date of grant. Vesting of stock options granted pursuant to the Company's stock incentive plans is determined by the Company's compensation committee. Generally, options granted to employees vest over four years and expire ten years from the date of grant. Options granted to non-employee directors have historically included cliff vesting after six months from the date of grant and expire three years from the date of grant. In fiscal years 2014 through 2016, the Company granted certain officers including its Chief Executive Officer and non-employee directors, and key employees shares of nonvested common stock instead of stock options. The vesting periods for the officers', the Chief Executive Officer's and the directors' nonvested stock awards are four years, three years and one year, respectively. The vesting period for the key employees' awards is four years.
 
We measure and recognize compensation expense for all stock-based payment awards made to employees and directors including employee stock options and awards of nonvested stock based on estimated fair values, as described in Note 1. Stock-based compensation expense incurred and recognized for the years ended September 30, 2016 and 2015 related to stock options and nonvested stock granted to employees and non-employee directors under the Company's stock incentive and employee stock purchase plans totaled approximately $414 thousand and $375 thousand, respectively. The classification of the cost of share-based compensation, in the statements of operations, is consistent with the nature of the services being rendered in exchange for the share based payment. The following table summarizes stock-based compensation expense in the Company's consolidated statements of operations:
 
Year ended
 
September 30, 2016
 
September 30, 2015
 
(Amounts in thousands)
Cost of sales
$
2

 
$
2

Engineering and development
6

 
22

Selling, general and administrative
406

 
351

Total
$
414

 
$
375

 
 
 
 

 
For the year ended September 30, 2016, the Company granted 28,000 nonvested shares to certain key employees, 57,000 nonvested shares to certain officers including 40,000 shares granted to the Chief Executive Officer, and 20,395 nonvested shares to its non-employee directors. For the year ended September 30, 2015, the Company granted 11,000 nonvested shares to certain key employees, 30,500 nonvested shares to certain officers including 12,000 to its Chief Executive Officer and 16,000 nonvested shares to its non-employee directors.
 
The Company measures the fair value of nonvested stock awards based upon the market price of its common stock as of the date of grant. The Company used the Black-Scholes option-pricing model to value stock options. The Black-Scholes model requires the use of a number of assumptions including volatility of the Company's stock price, the weighted average risk-free interest rate and the weighted average expected life of the options, at the time of grant. The expected dividend yield is equal to the divided per share declared, divided by the closing share price on the date the options were granted. All equity compensation awards granted for the years ended September 30, 2016 and September 30, 2015 were nonvested stock awards.
 
 
As stock-based compensation expense recognized in the consolidated statements of operations is based on awards ultimately expected to vest, expense for grants beginning upon adoption on October 1, 2005 has been reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The forfeiture rates for the years ended September 30, 2016 and 2015 were based on actual forfeitures.
 
No cash was used to settle equity instruments granted under share-base payment arrangements in any of the years in the two-year period ended September 30, 2016.
 
The following tables provide summary data of stock option award activity:
 
Number
of Shares
 
Weighted
average
exercise
price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
(in thousands)
 
 
 
 
 
 
 
 
Outstanding at September 30, 2014
92,126

 
$
7.66

 

 

Granted

 

 

 

Expired
(35,125
)
 
$
9.72

 

 

Forfeited

 

 

 

Exercised
(1,875
)
 
5.26

 

 

Outstanding at September 30, 2015
55,126

 
$
6.43

 

 

Granted

 

 

 

Expired
(17,500
)
 
$
6.61

 

 

Forfeited

 

 

 

Exercised
(14,000
)
 
6.20

 

 

Outstanding at September 30, 2016
23,626

 
$
5.76

 
1.53 Years

 
$
106

Exercisable at September 30, 2016
23,626

 
$
5.76

 
1.53 Years

 
$
106

Vested and expected to vest at September 30, 2016
23,626

 
$
5.76

 
1.53 Years

 
$
106


 
There were no stock options granted in the years ended September 30, 2016 and 2015. The aggregate intrinsic value of stock options exercised during the years ended September 30, 2016 and 2015 was $51 thousand and $3 thousand, respectively.
 
 
The following table provides summary data of nonvested stock award activity:
 
 
Number of
nonvested
shares
 
Weighted
Average
grant date
Fair
Value
 
Weighted
Average
Remaining
Contractual
Term 
 
Aggregate
Intrinsic
Value 
(in thousands)
 
 
Nonvested shares outstanding at September 30, 2014
149,375

 
$
6.92

 
2.45 years

 
$
1,191

Activity in 2015:
 

 
 

 
 

 
 

Granted
57,500

 
$
5.05

 

 

Vested
(58,296
)
 
$
6.82

 

 

Forfeited
(18,122
)
 
7.38

 

 

Nonvested shares outstanding at September 30, 2015
130,457

 
$
6.08

 
2.12 Years

 
$
714

Activity in 2016:
 

 
 

 
 

 
 

Granted
105,395

 
$
6.47

 

 

Vested
(48,444
)
 
$
6.33

 

 

Forfeited
(21,700
)
 
7.38

 

 

Nonvested shares outstanding at September 30, 2016
165,708

 
$
6.38

 
2.20 Years

 
$
1,695

Vested at September 30, 2016
179,277

 
$
5.57

 
0.36 Years

 
$
1,834

Vested and expected to vest at September 30, 2016
344,985

 
$
5.96

 
1.24 Years

 
$
3,529


 
As of September 30, 2016 there was $718 thousand of total unrecognized compensation cost related to nonvested share-based compensation arrangements (including stock option and nonvested stock awards) granted under the company's stock incentive plans. This cost is expected to be expensed over a weighted average period of approximately 2.51 years. The total fair value of shares vested during the years ended September 30, 2016 and 2015 was $307 thousand and $399 thousand, respectively.